Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check5 days agoChange DetectedThe related topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed from the study page. This reduces disease-specific tagging and can affect how the trial is discovered and indexed for schizophrenia-related searches.SummaryDifference0.0% 
- Check13 days agoChange DetectedRemoved MedlinePlus Genetics topic: Schizophrenia, reducing coverage of genetics-related schizophrenia content.SummaryDifference0.1% 
- Check20 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Schizophrenia. This introduces genetic health information to the page but there are no deletions or other core changes.SummaryDifference0.1% 
- Check27 days agoChange DetectedThe page update adds a funding-related operating disclaimer and a current status notice with revision v3.2.0, while removing the older Last Update and revision v3.1.0 references.SummaryDifference2% 
- Check34 days agoChange DetectedAdds numerous new phone numbers and a current date (2025-09-26) while removing many site contact entries and older update notes; core content and core features remain largely unchanged.SummaryDifference9% 
- Check41 days agoChange DetectedAdded MedlinePlus Genetics topic on schizophrenia, expanding core content coverage.SummaryDifference0.1% 
Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.